RELIZORBNEO
Live / Allowed — Published for opposition (as of 14 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99650609
- Mark type
- Word mark
- Filed
- 12 Feb 2026
- Published for opposition
- 14 Jul 2026
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and wound healing, mental illness, pulmonary, muscular and respiratory diseases and disorders
- Class 010 — Medical apparatus: Filters for medical purposes, namely, for processing and converting medical nutritional formula
Owner
- Alcresta Therapeutics, Inc., Waltham, MA, US
- Alcresta Therapeutics, Inc., Waltham, MA, US
Prior registrations
Prosecution history
- 14 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2026 — PUBLISHED FOR OPPOSITION
- 08 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jun 2026 — ASSIGNED TO EXAMINER
- 12 Jun 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 12 Feb 2026 — NEW APPLICATION ENTERED